PPT-Management of Anticoagulants & Antiplatelet Agents Pre and Post Endoscopy

Management of Anticoagulants amp Antiplatelet Agents Pre and Post Endoscopy Thomas Savides MD Professor of Clinical Medicine University of California San Diego Disclosures None Learning Objectives. Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. Research Advisory Committee. David . Kratville. Senior Environmental Scientist. CDFA – Integrated Pest Control Branch. Vertebrate Pests. Purpose of this training. Overview of rodenticides. History of VPCRAC. Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. Thomas Savides, M.D.. Professor of Clinical Medicine. University of California, San Diego. Disclosures. None. Learning Objectives. Accurately assess the risk of bleeding in patients on anticoagulants and antiplatelet agents before endoscopic procedures. Minilecture. Objectives. Indications for Antiplatelet Therapy in patients with CAD and ACS. Antiplatelet Therapy in the role of primary and secondary prevention of . c. ardiovascular events. CAD & the Vulnerable Plaque. Endoscopy is a medical procedure where a doctor puts a tube-like instrument into thebody to look inside There are many types of endoscopy each of which is designed forlooking at a certain part of the What is Upper EndoscopyUpper endoscopy enables your doctor to view the lining of the upper gastrointestinal tract including the esophagus stomach and duodenum the 31rst portion of the small intestine TAMERICAN BOARD OF SURGERYFOR GENERAL SURGERY RESIDENTSTable of Contentsclick to go to sectionABS Flexible Endoscopy Curriculum2LEVEL 1 PGY-1 or -4LEVEL II PGY-1 or -25LEVEL IIIPGY-2or -36LEVEL IVPGY , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. ?. That . major bleeding . occurs in about . 6.5% of patients on anticoagulants.. . That’s. . 1 patient in 15. . and commonly, GI Bleeding.. That . 1% . is . fatal bleeding . such as intracranial hemorrhage.. Anticoagulant therapy. (n = . 124). CADISS. P. rimary outcome. : . Ipsilateral . stroke or all-cause mortality . for antiplatelet vs. anticoagulation: 2. % . vs. 1%; p . = . 0.63. Any stroke: 2% vs. 1%, . existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo intracerebral haemorrhage (ICH): extended follow-up of the. RE. start. or . ST. op. . A. ntithrombotics. . R. andomised . T. rial. (RESTART) . RESTART Collaboration. www.RESTARTtrial.org. Intracerebral haemorrhage (ICH) is associated with an increased risk of arterial ischaemic events*: pooled analysis of 4 population-based cohorts. Conor Hamilton (Lecturer (Education)- Nursing QUB). c.hamilton@qub.ac.uk. Background. Endoscopy . is . dependent . on effective . team . work - evident . in emergency situations. . Emergencies in endoscopy are rare:.